Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 4/20 | 0.47 |
| ▸ | CYP26A1 | O43174 | 3/20 | 0.47 |
| ▸ | CYP26B1 | Q9NR63 | 1/20 | 0.47 |
| ▸ | RXRA | P19793 | 7/20 | 0.45 |
| ▸ | RXRB | P28702 | 6/20 | 0.45 |
| ▸ | RARA | P10276 | 8/20 | 0.42 |
| ▸ | RARB | P10826 | 8/20 | 0.42 |
| ▸ | RARG | P13631 | 8/20 | 0.42 |
| ▸ | RXRG | P48443 | 5/20 | 0.41 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.39 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.39 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8748673 | 0.87 | CYP26A1 (0.61) | CYP3A4CYP26A1CYP26B1RXRARXRB | |
| SCHEMBL8839101 | 0.84 | RXRA (0.48) | CYP3A4CYP26A1CYP26B1RXRARXRB | |
| SCHEMBL8839222 | 0.81 | RXRA (0.50) | CYP3A4CYP26A1CYP26B1RXRARXRB | |
| SCHEMBL8839100 | 0.81 | RXRA (0.45) | CYP3A4CYP26A1CYP26B1RXRARXRB | |
| SCHEMBL8100589 | 0.80 | RARB (0.44) | CYP3A4CYP26A1CYP26B1RXRARXRB | |
| SCHEMBL8102647 | 0.80 | CYP3A4 (0.41) | CYP3A4CYP26A1CYP26B1RXRARXRB | |
| SCHEMBL8839136 | 0.80 | RARB (0.52) | CYP3A4CYP26A1CYP26B1RXRARXRB | |
| SCHEMBL8102732 | 0.80 | RXRA (0.42) | CYP3A4CYP26A1CYP26B1RXRARXRB | |
| SCHEMBL8108641 | 0.80 | CYP3A4 (0.45) | CYP3A4CYP26A1CYP26B1RXRARXRB | |
| SCHEMBL8093126 | 0.79 | CYP26A1 (0.42) | CYP3A4CYP26A1CYP26B1RXRARXRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6051243-A | USEFUL IN THE TOPICAL AND SYSTEMIC TREATMENT OF DERMATOLOGICAL CONDITIONS ASSOCIATED WITH A KERATINIZATION DISORDER, DERMATOLOGICAL CONDITIONS (AND THE LIKE) INCLUDING AN INFLAMMATORY AND/OR IMMUNOALLERGIC COMPONENT | CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES (FR) | 2000-04-18 | — | — | US | disclosed |
| US-5709867-A | TREATMENT OF DERMATOLOGICAL, RHEUMATIC, RESPIRATORY, CARDIOVASCULAR, AND OPHTHALMOLOGICAL DISORDERS | CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (FR) | 1998-01-20 | — | — | US | disclosed |